Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
13 August 2019 | Story Lacea Loader | Photo Sonia Small
Student Success
The UFS is committed to student success through its own initiative.

In its endeavour to assist and support academically deserving students, taking into account the current economic climate in South Africa, the University of the Free State (UFS) has been able to maintain its approach to student success from its own initiative and in cooperation with external sources or partners. 
 
In addition, the university’s tuition fees remain on average 20% less than those of comparative universities.
 
“More than 70% of all registered undergraduate and postgraduate students at the UFS are receiving some kind of financial support – whether from the university or via external sources or partners, or from the National Student Financial Aid Scheme (NSFAS). In fact, financial support to students is one of the main expenses of the university,” says Mr Chris Liebenberg, Senior Director: Finance at the UFS. 
 
According to Mr Liebenberg, undergraduate bursaries to the value of R63 million and postgraduate bursaries to the value of R77 million have been allocated for 2019. These bursaries are funded by the UFS, as well as by external sources or partners and are awarded on merit, which includes academic, sport, and cultural performance. It excludes bursaries that students receive from NSFAS. 
 
“The university is able to provide this support to deserving students due to its stringent application of financial governance and discipline and within a framework of financial sustainability. It is a principle that the university management strongly believes in and will continue to apply,” says Mr Liebenberg. 

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept